2023 Clinic Government Individual 
Physician's Weekly
JUNE 26, 2025
However, we cannot overlook systemic factors, such as access to care, socioeconomic status, neighborhood safety, or walkability, that make it more challenging for some individuals to maintain a healthy weight. We also need to pick up on when a child is gaining weight rapidly or crossing percentiles so we can intervene earlier.
My Green Doctor
APRIL 4, 2025
According to the 2023 report of the Lancet Countdown, mortality caused by extreme heat events increased by 53.7% It tells your office colleagues and patients that your healthcare practice or clinic is committed to forging a healthier work space and community. from 2000 to 2018 among people over 65 years old. Let’s talk!
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law
NOVEMBER 2, 2023
Lewis, Senior Regulatory Device & Biologics Expert — On October 20, 2023, FDA announced the availability of the final guidance authored by CBER titled “Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies.” Tobolowsky & Richard A. It finalized a draft guidance published in 2022.
FDA Law
JUNE 27, 2024
After issuing an Order to Show Cause and Immediate Suspension of Registration in September 2022, and an administrative hearing in March 2023, DEA adopted the hearing Administrative Law Judge’s (“ALJ’s”) Recommended Decision to revoke Coconut Grove’s registration based on the public interest factors of 21 U.S.C. 21 U.S.C. § 823(g)(1)(B), (D).
Medical Xpress
JUNE 16, 2025
In a study published in Nature Communications , led by researchers at National Taiwan University (NTU) and National Tsing Hua University (NTHU), scientists used the deepest-ever two-photon calcium imaging in awake mice to directly observe how individual SCN neurons respond to light. Your feedback is important to us.
FDA Law
APRIL 8, 2024
What about government factors that cause drug shortages? What the White Paper does not adequately address is whether there are any government-controlled factors that also cause drug shortages. We recently summarized another GAO report which described challenges FDA continues to face with clinical research inspections.
FDA Law
OCTOBER 17, 2023
This implies that if device technologies and features can produce a clinically meaningful impact for the treatment or diagnosis of a condition in certain populations, such data could support the case that the device satisfies the first designation criterion. By Philip Won & Lisa M.
Expert insights. Personalized for you.
52 
Let's personalize your content